Residency · Residency · Medical Genetics Genomics
Long-Read Sequencing and Optical Genome Mapping
Introduction
Long-read sequencing (LRS) and optical genome mapping (OGM) are complementary technologies that address critical blind spots of short-read sequencing. By generating reads or molecular maps spanning tens to hundreds of kilobases, these platforms resolve structural variants, repeat expansions, complex rearrangements, and phasing that are invisible or ambiguous with conventional short-read approaches.
Long-Read Sequencing Technologies
Pacific Biosciences (PacBio) HiFi Sequencing
PacBio uses single-molecule real-time (SMRT) sequencing in zero-mode waveguides. Circular consensus sequencing (CCS) circularizes the DNA molecule so the polymerase traverses the insert multiple times, producing HiFi reads of 10-25 kb with accuracy exceeding 99.9% (Q30+). Simultaneous detection of base modifications (methylation) via kinetic signatures is possible. The current Revio system achieves throughput of approximately 90 Gb per SMRT cell.
Oxford Nanopore Technologies (ONT)
Oxford Nanopore works by translocating DNA through a protein nanopore embedded in a synthetic membrane, with current changes as nucleotides pass through the pore decoded into sequence. Read lengths are limited only by input DNA integrity, with reads exceeding 1 Mb achieved. Native DNA sequencing preserves epigenetic modifications (5mC, 5hmC, 6mA) without bisulfite conversion. Platforms range from the portable MinION (USB-powered) to the high-throughput PromethION. Per-read accuracy is approximately 95-99% with the latest chemistries (R10.4.1), reaching consensus accuracy above 99.9% with sufficient depth. Adaptive sampling enables real-time computational enrichment or depletion of target regions without physical capture.
Clinical Applications of Long-Read Sequencing
Structural Variant Detection
Long-read sequencing provides superior detection of deletions, duplications, insertions, inversions, and translocations compared to short-read sequencing. It resolves complex structural variants including chromothripsis and chromoanagenesis. Mobile element insertions (Alu, LINE-1, SVA) causing disease are identified. Clinically relevant examples include inversions at the F8 gene locus causing severe hemophilia A, complex rearrangements at NF1 involving pseudogene interference, and SVA insertions in TAF1 causing X-linked dystonia-parkinsonism.
Repeat Expansion Disorders
Long-read sequencing enables direct sizing of short tandem repeat (STR) expansions without Southern blot or specialized PCR. It simultaneously determines expansion size, interruption pattern, and somatic mosaicism. Applications include Fragile X syndrome (FMR1 CGG repeats) with methylation status, myotonic dystrophy types 1 and 2 (DMPK CTG, CNBP CCTG), Friedreich ataxia (FXN GAA repeats), C9orf72 hexanucleotide repeat expansions (ALS/FTD), and RFC1 pentanucleotide repeat expansions (CANVAS).
Phasing and Compound Heterozygosity
Long reads span multiple variants, enabling physical phasing without parental samples. This resolves whether two heterozygous variants in a recessive disease gene are in cis (same allele) or trans (different alleles), which is particularly valuable when parental samples are unavailable.
Pharmacogenomics
Long-read sequencing resolves complex loci such as CYP2D6 (gene deletions, duplications, hybrid alleles) that are poorly characterized by short-read sequencing. Complete HLA typing from long-read data is also achievable.
Optical Genome Mapping
Technology Overview
The Bionano Saphyr system is the primary clinical OGM platform. Ultra-high molecular weight DNA (median greater than 250 kb) is labeled at specific sequence motifs with fluorescent tags. Labeled molecules are linearized in nanochannels and imaged. Fluorescent label patterns create a molecular barcode that is aligned to a reference genome. OGM does not provide base-level sequence information; it identifies structural alterations by pattern disruption.
Capabilities
OGM detects structural variants larger than 500 bp with high sensitivity and specificity. It identifies balanced translocations and inversions missed by microarray, detects copy number changes across the genome, and resolves complex rearrangements in a single assay. It is useful for characterizing marker chromosomes and ring chromosomes.
Clinical Applications
In constitutional cytogenetics, OGM serves as a potential replacement or complement to karyotype and FISH. For hematologic malignancies, it detects prognostically relevant translocations, deletions, and complex karyotypes. In prenatal diagnostics, it characterizes structural rearrangements detected by other methods. In research, it facilitates discovery of novel structural variants in undiagnosed rare disease.
Limitations
OGM does not detect single nucleotide variants or small indels, balanced rearrangements smaller than 500 bp, or repeat expansion sizes at the sequence level. It requires fresh or carefully preserved samples for ultra-high molecular weight DNA extraction. It is not yet widely available in clinical laboratories, and validation standards are evolving.
Integrating Technologies
| Feature | Short-Read WGS (Illumina) | PacBio HiFi | Oxford Nanopore | Optical Genome Mapping (Bionano) |
|---|---|---|---|---|
| Read length | 150–300 bp | 10–25 kb | Up to >1 Mb | Molecular maps >250 kb |
| Per-read accuracy | >99.9% | >99.9% (Q30+) | ~95–99% (R10.4.1) | N/A (pattern-based) |
| SNV/indel detection | Excellent | Excellent | Good (improving) | No |
| Structural variants | Limited (<50 bp well; larger SVs missed) | Excellent | Excellent | Excellent (>500 bp) |
| Repeat expansions | Poor | Excellent (with sizing + interruptions) | Excellent | Limited |
| Methylation | Requires bisulfite conversion | Native (kinetic signatures) | Native (direct) | No |
| Phasing | Requires parental samples or statistical | Physical phasing from long reads | Physical phasing from long reads | Haplotype-aware |
| Balanced rearrangements | Poor | Good | Good | Excellent |
| Relative cost | Lowest | 2–5x short-read | 1.5–3x short-read | Similar to short-read |
Complementary Approaches
Short-read WGS combined with OGM provides base-level resolution with structural variant sensitivity. Short-read WGS with targeted long-read sequencing uses long reads to resolve specific complex regions identified by short-read analysis. Long-read WGS as a standalone platform is emerging as a comprehensive single-platform solution for SNVs, indels, SVs, repeat expansions, methylation, and phasing, with cost and throughput as primary barriers.
Current Practical Considerations
Long-read WGS cost remains 2-5x higher than short-read WGS. Bioinformatics tools for long-read data are rapidly maturing, including pbsv, Sniffles2, TRGT, and Clair3. Clinical laboratory validation for long-read platforms is ongoing at multiple centers. Rapid nanopore sequencing has been demonstrated for NICU applications with sub-8-hour turnaround.
Clinical Pearls
Long-read sequencing resolves the three major blind spots of short-read sequencing: structural variants, repeat expansions, and phasing. Optical genome mapping complements sequencing by providing genome-wide structural variant detection without base-level resolution. Native long-read sequencing can simultaneously assess sequence and methylation, which is particularly valuable for imprinting disorders and repeat expansion characterization. The clinical genetics field is moving toward multi-platform approaches, but long-read WGS may eventually serve as a single comprehensive test.
References
- Logsdon GA, Vollger MR, Eichler EE. Long-read human genome sequencing and its applications. Nature Reviews Genetics. 2020;21(10):597-614.
- Dremsek P, Schwarz T, Weil B, et al. Optical genome mapping in routine human genetics diagnostics. American Journal of Human Genetics. 2021;108(8):1409-1422.
- Mastrorosa FK, Miller DE, Eichler EE. Applications of long-read sequencing to Mendelian genetics. Genome Medicine. 2023;15:42.
- Pauper M, Kucuk E, Wenger AM, et al. Long-read trio sequencing of individuals with unsolved intellectual disability. European Journal of Human Genetics. 2021;29(4):637-648.